- Home
- WLDS vs FBIOP Comparison
WLDS vs FBIOP Comparison
Compare WLDS & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- FBIOP
- Stock Information
- Founded
- WLDS 2014
- FBIOP N/A
- Country
- WLDS Israel
- FBIOP United States
- Employees
- WLDS N/A
- FBIOP 101
- Industry
- WLDS Computer Communications Equipment
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- FBIOP Health Care
- Exchange
- WLDS Nasdaq
- FBIOP Nasdaq
- Market Cap
- WLDS N/A
- FBIOP N/A
- IPO Year
- WLDS 2022
- FBIOP N/A
- Fundamental
- Price
- WLDS $1.59
- FBIOP $6.74
- Analyst Decision
- WLDS
- FBIOP
- Analyst Count
- WLDS 0
- FBIOP 0
- Target Price
- WLDS N/A
- FBIOP N/A
- AVG Volume (30 Days)
- WLDS 138.7K
- FBIOP N/A
- Earning Date
- WLDS 12-24-2024
- FBIOP N/A
- Dividend Yield
- WLDS N/A
- FBIOP N/A
- EPS Growth
- WLDS N/A
- FBIOP N/A
- EPS
- WLDS N/A
- FBIOP N/A
- Revenue
- WLDS $522,000.00
- FBIOP N/A
- Revenue This Year
- WLDS N/A
- FBIOP N/A
- Revenue Next Year
- WLDS N/A
- FBIOP N/A
- P/E Ratio
- WLDS N/A
- FBIOP N/A
- Revenue Growth
- WLDS 536.59
- FBIOP N/A
- 52 Week Low
- WLDS $1.65
- FBIOP N/A
- 52 Week High
- WLDS $54.40
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- WLDS 47.97
- FBIOP 67.87
- Support Level
- WLDS $1.86
- FBIOP $6.00
- Resistance Level
- WLDS $3.10
- FBIOP $6.80
- Average True Range (ATR)
- WLDS 0.35
- FBIOP 0.42
- MACD
- WLDS 0.05
- FBIOP 0.16
- Stochastic Oscillator
- WLDS 28.99
- FBIOP 96.19
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.